invert
发表于 2025-3-25 06:14:00
Yukun Yang,Wenhu Qin,Libo Sun,Weipeng Shier the past decade remain high with the reduced survival rate of the patient, despite many advanced conventional and research clinical practices. Therefore, there is an urgent requirement for novel screening methods to diagnose tumor at its earlier stages with the development of predictive markers a
JEER
发表于 2025-3-25 09:26:50
https://doi.org/10.1007/978-3-031-23473-6n in Western countries than in Asia. However, currently, CRC incidence rate is high in Asian countries and accounts for the greatest number of cancer death. Therefore, different factors responsible for these changes in CRC incidence rate in Western countries and Asian countries need to be identified
载货清单
发表于 2025-3-25 12:04:37
https://doi.org/10.1007/978-3-031-50075-6he second most frequent cancer in women after breast cancer. Dietary factors account for nearly half of all CRC cases. Diet has a paramount role in the development of CRC. In the past few decades, findings from widespread epidemiologic and experimental exploration have linked ingestion of numerous f
高度表
发表于 2025-3-25 16:03:55
http://reply.papertrans.cn/23/2297/229656/229656_24.png
extinguish
发表于 2025-3-25 22:15:35
http://reply.papertrans.cn/23/2297/229656/229656_25.png
Intractable
发表于 2025-3-26 03:06:22
http://reply.papertrans.cn/23/2297/229656/229656_26.png
MOAT
发表于 2025-3-26 06:00:20
http://reply.papertrans.cn/23/2297/229656/229656_27.png
excrete
发表于 2025-3-26 10:03:09
Yin Chen,Yuhao Zhou,Tianyang Dong to its higher incidence and metastatic actions. The molecules expressed by the cancer tissues help to develop several novel approaches in cancer treatment. Nowadys, nanotechnology offers an advanced method for the identification and colon cancer therapy which are capable of overcoming biophysical a
GONG
发表于 2025-3-26 14:29:35
http://reply.papertrans.cn/23/2297/229656/229656_29.png
蚀刻
发表于 2025-3-26 20:47:12
https://doi.org/10.1007/978-3-030-89029-2e current treatment therapies for CRC are increasing nowadays since there are large variations seen among individuals in terms of diagnosis and response to drugs used to manage CRC owing to biomolecular heterogeneity. Around 15% of CRC cases are due to defect in the DNA mismatch repair (MMR) system,